Mariner
PASG icon

Mariner’s Passage Bio PASG Stock Holding History

Mariner’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-597
Closed -$4.78K – 3707
2025
Q2 		$4.78K Hold
597
– – ﹤0.01% 3463
2025
Q1 		$4.21K Buy
+597
New +$6.45K ﹤0.01% 3425

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner's PASG Position: Q3 2025 in Review

Mariner sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 597 shares — an estimated $4.78K sold.

Mariner first reported a position in PASG in Q1 2025 and held it in 2 quarters. The position peaked at $4.78K in Q2 2025. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Mariner reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 597 Passage Bio shares in Q3 2025, an estimated $4.78K.
  • Mariner first reported a position in Passage Bio in Q1 2025 and held it in 2 quarters.
  • Mariner's Passage Bio position peaked at $4.78K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.